Fragment-based Lead Discovery Conference 2008
|
|
**IMPORTANT FBLD 2009 UPDATE! The FBLD 2009 Conference will be held Sep 21st - 23rd 2009 in York, UK. Visit fbld2009.com for more information! **
Discover How Fragment-based Lead Discovery Shortens Drug Discovery Timelines
Need novel leads? Join us in San Diego, February 18-20, for an interdisciplinary and interactive conference on Fragment-based Lead Discovery (FBLD), a technique with demonstrated success in rapid, novel lead generation for drug discovery. FBLD's strength lies in its utilization of several complementary techniques, such as X-ray crystallography, NMR, surface plasmon resonance, and calorimetry, to produce tightly binding drug-like leads. At FBLD 2008, you'll learn from the pioneers in the field along with scientists actively using FBLD to accelerate drug discovery. Register or sign up for updates now!
Scientific Advisory Board
Martin Drysdale, Director of Chemistry
& Structural Science, Vernalis
Daniel Erlanson,Associate Director, Medicinal
Chemistry, Sunesis
Roderick Hubbard, Professor, University of
York and Senior Fellow, Vernalis
Wolfgang Jahnke, Senior Research Investigator,
Novartis
Harren Jhoti, CEO & Founder, Astex Therapeutics
Duncan McRee, President,ActiveSight
Vicki Nienaber, Chief Scientific Officer,
ActiveSight
Maurizio Pellecchia, Professor, Burnham
Institute for Medical Research
Focus on Science in a Casual Atmosphere
The conference will take place at Paradise Point Resort & Spa, located on a 44 acre private island on San Diego Bay. Special emphasis will be placed on cultivating meaningful scientific interactions in a casual atmosphere. In addition, the leading technologies will be presented in workshops and demonstrations, enabling attendees to bring home practical information on a wide variety of FBLD techniques. FBLD 2008 is being organized by ActiveSight and Rigaku, leaders in FBLD equipment and expertise.